Developing a New Tool to Study Viral Infections and Cancer in Dogs
In humans, a powerful immunologic reagent called a tetramer is standardly used to visualize changes in the body’s killer T-cells. These cells respond to immunologic challenges and are critical to the body’s immune system. Current knowledge of T-cell behavior in dogs could be significantly advanced with the development of a dog-specific tetramer. Researchers will work to construct the first canine tetramer, which would then be used in the development of vaccines for infectious diseases and cancer in dogs.
Principal Investigator: Dr. Paul R. Hess, North Carolina State University
Study ID: D15CA-015